| RS2506726269 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Inborn genetic diseases |
| RS2506726285 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506726338 |
SRCAP
|
Health Risk |
Likely pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS2506726491 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506726518 |
SRCAP
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2506726581 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506727018 |
SRCAP
|
Health Risk |
Likely pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS2506727078 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506727189 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506728534 |
SRCAP
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2506729448 |
SRCAP
|
Health Risk |
Likely pathogenic |
Floating-Harbor syndrome, Floating-Harbor syndrome |
| RS2506730506 |
SRCAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Floating-Harbor syndrome, Developmental delay |
| RS2506731130 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506732204 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506737906 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506800550 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2506802256 |
CYLD
|
Health Risk |
Pathogenic |
Brooke-Spiegler syndrome, Brooke-Spiegler syndrome |
| RS2506820899 |
CYLD
|
Health Risk |
Pathogenic |
CYLD-related disorder, CYLD-related disorder |
| RS2506824551 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS2506825899 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2506828315 |
CDH11
|
Health Risk |
Likely pathogenic |
— |
| RS2506837428 |
VPS35L
|
Health Risk |
Likely pathogenic |
Ritscher-Schinzel syndrome 3, Ritscher-Schinzel syndrome 3 |
| RS2506847638 |
EARS2
|
Health Risk |
Pathogenic |
— |
| RS2506849137 |
CYLD
|
Health Risk |
Pathogenic |
— |
| RS2506858241 |
GNAO1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2506862962 |
CYLD
|
Health Risk |
Likely pathogenic |
Brooke-Spiegler syndrome, Brooke-Spiegler syndrome |
| RS2506863798 |
EARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS2506871916 |
GNAO1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS2506872117 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
GNAO1-related disorder, Early-infantile DEE |
| RS2506872240 |
GNAO1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2506876806 |
GNAO1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2506887464 |
GNAO1
|
Health Risk |
Likely pathogenic |
— |
| RS2506891667 |
KATNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2506891682 |
EARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS2506891792 |
KATNB1
|
Health Risk |
Pathogenic |
— |
| RS2506892252 |
EARS2
|
Health Risk |
Likely pathogenic |
EARS2-related disorder, EARS2-related disorder |
| RS2506893332 |
CDH11
|
Health Risk |
Likely pathogenic |
Teebi hypertelorism syndrome 2, Teebi hypertelorism syndrome 2 |
| RS2506903755 |
CYLD
|
Health Risk |
Likely pathogenic |
Brooke-Spiegler syndrome, Brooke-Spiegler syndrome |
| RS2506910748 |
KATNB1
|
Health Risk |
Likely pathogenic |
KATNB1-related disorder, KATNB1-related disorder |
| RS2506913635 |
PARN
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS2506913971 |
EARS2
|
Health Risk |
Pathogenic |
— |
| RS2506943395 |
VPS35L
|
Health Risk |
Pathogenic |
Ritscher-Schinzel syndrome 3, Ritscher-Schinzel syndrome 3 |
| RS2506953147 |
MYH11
|
Health Risk |
Pathogenic |
— |
| RS2506956201 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2506957305 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2506958652 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia |
| RS2506960798 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2506961673 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2506961955 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group I |
| RS2506971137 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2506971268 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2506971572 |
OTOA
|
Health Risk |
Likely pathogenic |
— |
| RS2506973246 |
GPRC5B
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 3, Megalencephalic leukoencephalopathy with subcortical cysts 3 |
| RS2506973258 |
GPRC5B
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 3, Megalencephalic leukoencephalopathy with subcortical cysts 3 |
| RS2506980081 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2506981791 |
DHODH
|
Health Risk |
Pathogenic |
— |
| RS2506989427 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2506990331 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2506997702 |
AARS1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 29 |
| RS2506997974 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2507002278 |
HSF4
|
Health Risk |
Pathogenic |
Cataract 5 multiple types, Cataract 5 multiple types |
| RS2507003569 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2507012689 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2507013974 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2507014327 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2507016563 |
AARS1
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy, hereditary diffuse |
| RS2507018118 |
AARS1
|
Health Risk |
Likely pathogenic |
Trichothiodystrophy 8, nonphotosensitive |
| RS2507018497 |
HSF4
|
Health Risk |
Pathogenic |
Cataract 5 multiple types, Cataract 5 multiple types |
| RS2507020531 |
AARS1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2507028484 |
AARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease axonal type 2N |
| RS2507029458 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507033596 |
OTOA
|
Health Risk |
Likely pathogenic |
— |
| RS2507033670 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507033841 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507033909 |
OTOA
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS2507034326 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507037782 |
AARS1
|
Health Risk |
Likely pathogenic |
— |
| RS2507039180 |
OTOA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 22, Autosomal recessive nonsyndromic hearing loss 22 |
| RS2507041538 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2507049524 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507049541 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507055972 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2507056779 |
KARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
KARS1-related disorder, Leukoencephalopathy |
| RS2507058446 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507058720 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2507058861 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507058870 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507058940 |
OTOA
|
Health Risk |
Likely pathogenic |
— |
| RS2507063974 |
OTOA
|
Health Risk |
Pathogenic |
— |
| RS2507063979 |
OTOA
|
Health Risk |
Likely pathogenic |
OTOA-related disorder, OTOA-related disorder |
| RS2507068066 |
TK2
|
Health Risk |
Pathogenic |
— |
| RS2507068187 |
TK2
|
Health Risk |
Pathogenic |
— |
| RS2507073619 |
TERF2IP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2507088209 |
TK2
|
Health Risk |
Pathogenic |
— |
| RS2507089875 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2507091300 |
TK2
|
Health Risk |
Pathogenic |
— |
| RS2507091550 |
TK2
|
Health Risk |
Pathogenic |
— |
| RS2507094576 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2507094628 |
IFT140
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 80, Retinitis pigmentosa 80 |
| RS2507105477 |
DHX38
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |